Approval · Notice of Compliance 34211 · 2024
TEVA-HALOPERIDOL: Notice of Compliance 34211
Issued October 16, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34211
- Date
- October 16, 2024
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-HALOPERIDOL | Not yet assigned | — |
Medicinal ingredients
- HALOPERIDOL 0.5 MG per TAB
- HALOPERIDOL 1 MG per TAB
- HALOPERIDOL 2 MG per TAB
- HALOPERIDOL 5 MG per TAB
- HALOPERIDOL 10 MG per TAB